Table 2. Treatment details of definitive chemoradiation.
| Variable | Overall (n = 17) |
|---|---|
| Chemotherapy regimen used for CCRT | |
| Mitomycin + 5’FU | 13 (76.5%) |
| Mitomycin + capecitabine | 4 (23.5%) |
| Dose of 5’FU (n = 13) | |
| 1,000 mg/m2 | 12 (70.6%) |
| 750 mg/m2 | 1 (5.9%) |
| Dose of capecitabine (n = 4) | |
| 825 mg/m2 | 4 (23.5%) |
| Dose of mitomycin | |
| 10 mg/m2 | 13 (76.5%) |
| 15 mg/m2 | 3 (17.6%) |
| 8 mg/m2 | 1 (5.9%) |
| Dose modification needed | |
| Yes | 1 (5.9%) |
| No | 16 (94.1%) |
| Fractions of radiotherapy (in number) | |
| 28 | 2 (11.8%) |
| 30 | 1 (5.9%) |
| 33 | 14 (82.4%) |
| Total dose of radiotherapy (in Gy) | |
| 5,040 | 2 (11.8%) |
| 5,940 | 14 (82.4%) |
| 6,000 | 1 (5.9%) |
| Technique of radiotherapy | |
| Intensity-modulated radiotherapy | 10 (58.8%) |
| Three-dimensional conformal radiotherapy | 7 (41.1%) |
| Duration of treatment (in weeks) | |
| Mean (SD) | 6.62 (0.697) |
| Median (Min, Max) | 6.50 (6.00, 9.00) |
| Any interruption in treatment | |
| Yes | 2 (11.8%) |
| No | 15 (88.2%) |
| Reason of interruption | |
| Infection | 2 |
| Toxicity | 0 |